Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)Chung‐Feng Huang, Ming‐Lung Yu, Rong‐Nan Chien et al.|The American Journal of Gastroenterology|2020Cited by 27
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort)Wei‐Fan Hsu, Cheng‐Yuan Peng, Pei‐Chien Tsai et al.|Journal of Gastroenterology and Hepatology|2021Cited by 23
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized TrialPin‐Nan Cheng, Pei‐Jer Chen, Chun‐Jen Liu et al.|Clinical Gastroenterology and Hepatology|2021Cited by 21
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapyPei‐Chien Tsai, Chung‐Feng Huang, Ming‐Lun Yeh et al.|Clinical and Molecular Hepatology|2024Cited by 18
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non‐cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysisChen‐Hua Liu, Jia‐Horng Kao, Yu‐Lueng Shih et al.|Journal of Gastroenterology and Hepatology|2019Cited by 9